Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
47.6M
-
Shares change
-
+47.6M
-
Total reported value, excl. options
-
$349M
-
Value change
-
+$349M
-
Number of buys
-
79
-
Price
-
$7.35
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2017
83 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2017.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.6M shares
of 334M outstanding shares and own 14.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.07M shares), FRANKLIN RESOURCES INC (5.15M shares), PERCEPTIVE ADVISORS LLC (4.36M shares), venBio Select Advisor LLC (4.15M shares), ACUTA CAPITAL PARTNERS, LLC (3.42M shares), ORBIMED ADVISORS LLC (3.38M shares), FMR LLC (2.83M shares), VICTORY CAPITAL MANAGEMENT INC (2.59M shares), Broadfin Capital, LLC (2.28M shares), and VANGUARD GROUP INC (2.19M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.